KLP Kapitalforvaltning
CRL icon

KLP Kapitalforvaltning’s Charles River Laboratories CRL Stock Holding History

KLP Kapitalforvaltning’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.3M Hold
11,200
– – 0.01% 567
2026
Q2 		$2.54M Sell
11,200
-1,400
-11% -$249K 0.01% 666
2026
Q1 		$2.17M Sell
12,600
-200
-2% -$37.1K 0.01% 683
2025
Q4 		$2.55M Sell
12,800
-100
-0.8% -$18.1K 0.01% 622
2025
Q3 		$2.02M Buy
12,900
+2,800
+28% +$445K 0.01% 701
2025
Q2 		$1.53M Buy
10,100
+200
+2% +$26.7K 0.01% 771
2025
Q1 		$1.49M Sell
9,900
-9,600
-49% -$1.61M 0.01% 753
2024
Q4 		$3.6M Buy
+19,500
New +$3.76M 0.02% 536

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Ariel Investments
Ariel Investments Chicago, Illinois $9.6B AUM 22.21% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $25.4B AUM 35.48% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return

KLP Kapitalforvaltning's CRL Position: Q3 2026 in Review

KLP Kapitalforvaltning held its Charles River Laboratories (CRL) position steady in Q3 2026 at 11,200 shares worth $3.3M. The position accounts for 0.01% of the portfolio, ranked #567.

KLP Kapitalforvaltning first reported a position in CRL in Q4 2024 and has held it in 8 quarters since. The position peaked at $3.6M in Q4 2024. 515 funds tracked by Wall St. Rank hold CRL as of Q3 2026.

  • KLP Kapitalforvaltning held 11,200 shares of Charles River Laboratories worth $3.3M as of Q3 2026.
  • KLP Kapitalforvaltning left its Charles River Laboratories share count unchanged in Q3 2026.
  • Charles River Laboratories made up 0.01% of KLP Kapitalforvaltning's portfolio in Q3 2026, its #567 holding.
  • KLP Kapitalforvaltning first reported a position in Charles River Laboratories in Q4 2024 and has held it in 8 quarters since.
  • KLP Kapitalforvaltning's Charles River Laboratories position peaked at $3.6M in Q4 2024.
  • 515 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q3 2026, filed 10 Nov 2026.